Collegium Pharmaceutical Inc reports results for the quarter ended in September - Earnings Summary

Collegium Pharmaceutical

04/11/2021 21:03

* Collegium Pharmaceutical Inc  COLL.OQ  reported quarterly
adjusted earnings of 22 cents​​ per share for the quarter ended
in September. The mean expectation of seven analysts for the
quarter was for earnings of 95 cents per share.
* Revenue fell 0.4% to $78.84 million from a year ago;  analysts
expected $84.89 million. 
* Collegium Pharmaceutical Inc's reported EPS for the quarter
was 22 cents​.
* The mean earnings estimate of analysts had risen by
about 51.1% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Collegium Pharmaceutical Inc shares had risen by 1.9% this
quarter and gained 0.4% so far this year.
* The company reported quarterly net income of $8.05 million.
* Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $28.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated November 4 at 09:02 p.m.
 ​All figures in US dollars unless otherwise stated